Coherus BioSciences Inc
NASDAQ:CHRS

Watchlist Manager
Coherus BioSciences Inc Logo
Coherus BioSciences Inc
NASDAQ:CHRS
Watchlist
Price: 2.12 USD -2.3% Market Closed
Updated: May 19, 2024

Coherus BioSciences Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Coherus BioSciences Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Coherus BioSciences Inc
NASDAQ:CHRS
Selling, General & Administrative
-$188.7m
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-35%
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$13B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is Coherus BioSciences Inc's Selling, General & Administrative?
Selling, General & Administrative
-188.7m USD

Based on the financial report for Mar 31, 2024, Coherus BioSciences Inc's Selling, General & Administrative amounts to -188.7m USD.

What is Coherus BioSciences Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-35%

Over the last year, the Selling, General & Administrative growth was 4%. The average annual Selling, General & Administrative growth rates for Coherus BioSciences Inc have been -10% over the past three years , -11% over the past five years , and -35% over the past ten years .